Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis-Reference-Cited by-同舟云学术

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

Published:2008-02 Issue:2 Volume:121 Page:519-526
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

de Olano David González,Álvarez-Twose Iván,Esteban-López María I.,Sánchez-Muñoz Laura,de Durana María D. Alonso Díaz,Vega Arantza,García-Montero Andres,González-Mancebo Eloina,Belver Teresa,Herrero-Gil María D.,Fernández-Rivas Montserrat,Orfao Alberto,de la Hoz Belén,Castells Mariana C.,Escribano Luis

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain. A Study of the Spanish Network on Mastocytosis (REMA);González de Olano;Clin Exp Allergy,2007

2. Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis;Akin;J Allergy Clin Immunol,2003

3. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes;Florian;Int Arch Allergy Immunol,2005

4. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome;Sonneck;Int Arch Allergy Immunol,2007

5. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy;Haeberli;Clin Exp Allergy,2003

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based data support strategies for the prevention of Hymenoptera venom anaphylaxis;Current Opinion in Allergy & Clinical Immunology;2024-07-22

2. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated Reactions;Current Allergy and Asthma Reports;2024-03-09

3. Anaphylaxis: A 2023 practice parameter update;Annals of Allergy, Asthma & Immunology;2024-02

4. Immunotherapy in patients with the first type of hypersensitivity to Hymenoptera venoms;Medicinski podmladak;2023

5. TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28